Wells Fargo Downgrades WuXi PharmaTech (WX) to Market Perform; Valuation Call - Questioning Acquisition Target
Go back to Wells Fargo Downgrades WuXi PharmaTech (WX) to Market Perform; Valuation Call - Questioning Acquisition Target| CHARLES RIVER LABORATORIE (NYSE: CRL) | Delayed: 290.00 +10.81 (3.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $279.19 | 52 Week High | $89.18 | |||
| Open | $284.22 | 52 Week Low | $65.70 | |||
| Day High | $294.56 | P/E | 134.88 | |||
| Day Low | $280.68 | EPS | $2.15 | |||
| Volume | 987,427 | |||||
| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 552.06 +23.87 (4.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $528.19 | 52 Week High | $134.71 | |||
| Open | $537.47 | 52 Week Low | $73.31 | |||
| Day High | $553.69 | P/E | N/A | |||
| Day Low | $532.55 | EPS | $-1.98 | |||
| Volume | 1,437,678 | |||||
| WUXI PHARMATECH (NYSE: WX) | Delayed: 25.00 +0.17 (0.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.83 | 52 Week High | $46.14 | |||
| Open | $25.04 | 52 Week Low | $32.50 | |||
| Day High | $25.04 | P/E | N/A | |||
| Day Low | $25.00 | EPS | $0.00 | |||
| Volume | 327 | |||||

